Meeting: World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC or Advisory Committee), National Institute for Occupational Safety and Health (NIOSH), 63790-63791 [2015-26759]
Download as PDF
<![CDATA[
63790
Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices
orthopedists, payors, and various
personnel not previously receiving a
copy, a copy of the Order and the
Complaint.
Paragraphs VII, VIII, and IX impose
various obligations on Keystone and
Orthopaedic Associates to report or
provide access to information to the
Commission to facilitate the monitoring
of compliance with the Order. Finally,
Paragraph X provides that the Order
will expire in 10 years from the date it
is issued.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2015–26690 Filed 10–20–15; 8:45 am]
Christine Harada, Associate Administrator
for Governmentwide Policy.
Thomas Sharpe, Jr., Commissioner, Federal
Acquisition Service.
Kevin Youel Page, Deputy Commissioner,
Federal Acquisition Service.
Norman Dong, Commissioner, Public
Buildings Service.
Michael Gelber, Deputy Commissioner,
Public Buildings Service.
Giancarlo Brizzi, Principal Deputy
Associate Administrator for Governmentwide
Policy.
Joanna Rosato, Regional Commissioner,
Public Buildings Service, Mid-Atlantic
Region.
Kim Brown, Regional Commissioner,
Federal Acquisition Service, Great Lakes
Region.
Dated: October 15, 2015.
Denise T. Roth,
Administrator, General Services
Administration.
BILLING CODE 6750–01–P
GENERAL SERVICES
ADMINISTRATION
[FR Doc. 2015–26661 Filed 10–20–15; 8:45 am]
[Notice-CX–2015–01; Docket No. 2015–0002;
Sequence 21]
BILLING CODE 6820–34–P
SES Performance Review Board
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
General Services
Administration.
ACTION: Notice.
AGENCY:
Centers for Disease Control and
Prevention
Notice is hereby given of the
appointment of new members to the
General Services Administration Senior
Executive Service Performance Review
Board. The Performance Review Board
assures consistency, stability, and
objectivity in the performance appraisal
process.
DATES: Effective: October 21, 2015.
FOR FURTHER INFORMATION CONTACT:
Antonia T. Harris, Chief Human Capital
Officer, Office of Human Resources
Management, General Services
Administration, 1800 F Street NW.,
Washington, DC 20405, 202–501–0398.
SUPPLEMENTARY INFORMATION: Section
4314(c)(1), through (5) of title 5 U.S.C.,
requires each agency to establish, in
accordance with regulations prescribed
by the Office of Personnel Management,
one or more SES performance review
board(s). The board is responsible for
making recommendations to the
appointing and awarding authority on
the performance appraisal ratings and
performance awards for the Senior
Executive Service employees.
The following have been designated
as members of the Performance Review
Board of the General Services
Administration:
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
Adam Neufeld, Deputy Administrator—
Chair.
Antonia Harris, Chief Human Capital
Officer.
Jerome Fletcher, Associate Administrator
for Small Business Utilization.
VerDate Sep<11>2014
22:39 Oct 20, 2015
Jkt 238001
[Docket Number CDC–2015–0090; NIOSH
248–C]
Meeting: World Trade Center Health
Program Scientific/Technical Advisory
Committee (WTCHP STAC or Advisory
Committee), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 9 a.m.–5 p.m., Eastern
Standard Time, December 1, 2015
Place: Jacob J. Javits Federal Building,
26 Federal Plaza, New York, New York
10278. This meeting is also available by
teleconference. The USA toll-free, dialin number is 1–888–455–9749, and
when prompted enter passcode—
6542002. To view the web conference,
enter the following web address in your
web browser: https://
odniosh.adobeconnect.com/wtchpstac/.
Public Comment Time and Date:
11:20 a.m.–12 p.m., Eastern Standard
Time, December 1, 2015
Please note that the public comment
period ends at the time indicated above
or following the last call for comments,
whichever is earlier. Members of the
public who want to comment must sign
up by providing their name by mail,
email, or telephone, at the addresses
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
provided below by November 27, 2015.
Each commenter will be provided up to
five minutes for comment. A limited
number of time slots are available and
will be assigned on a first come-first
served basis. Written comments will
also be accepted from those unable to
attend the public session.
Status: Open to the public, limited
only by the number of telephone lines.
The conference line will accommodate
up to 50 callers; therefore it is suggested
that those interested in calling in to
listen to the committee meeting share a
line when possible.
Background: The Advisory Committee
was established by Public Law 111–347
(The James Zadroga 9/11 Health and
Compensation Act of 2010, Title XXXIII
of the Public Health Service Act),
enacted on January 2, 2011 and codified
at 42 U.S.C. 300mm–300mm-61.
Purpose: The purpose of the Advisory
Committee is to review scientific and
medical evidence and to make
recommendations to the Administrator
of the World Trade Center (WTC) Health
Program regarding additional WTC
Health Program eligibility criteria and
potential additions to the list of covered
WTC-related health conditions, as well
as providing consultation on research to
the Administrator of the World Trade
Center Health Program. Title XXXIII of
the Public Health Service Act
established within the Department of
Health and Human Services (HHS), the
World Trade Center (WTC) Health
Program, to be administered by the
Administrator of the World Trade
Center Health Program. The WTC
Health Program provides: (1) Medical
monitoring and treatment benefits to
eligible emergency responders and
recovery and cleanup workers
(including those who are Federal
employees) who responded to the
September 11, 2001, terrorist attacks,
and (2) initial health evaluation,
monitoring, and treatment benefits to
residents and other building occupants
and area workers in New York City, who
were directly impacted and adversely
affected by such attacks (‘‘survivors’’).
Certain specific activities of the
Administrator of the World Trade
Center Health Program are reserved to
the Secretary, HHS, to delegate at her
discretion; other duties of the
Administrator of the World Trade
Center Health Program not explicitly
reserved to the Secretary, HHS, are
assigned to the Director, NIOSH. The
administration of the Advisory
Committee established under Section
300mm–1(a) is left to the Director of
NIOSH in his role as Administrator of
the World Trade Center Health Program.
CDC and NIOSH provide funding,
E:\FR\FM\21OCN1.SGM
21OCN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 203 / Wednesday, October 21, 2015 / Notices
staffing, and administrative support
services for the Advisory Committee.
The charter was reissued on May 12,
2015, and will expire on May 12, 2017.
Matters for Discussion: The Advisory
Committee will continue its
deliberations from the meeting on June
4, 2015, addressing the need for
research on developmental or health
effects in children. The agenda will
include presentations on children’s
health research that has been conducted
related to exposures from the 9/11
terrorist attacks. Also, a panel of
children’s researchers will discuss
children’s research issues with the
Advisory Committee.
The agenda is subject to change as
priorities dictate.
Public Comment Sign-up and
Submissions to the Docket: To sign up
to provide public comments or to
submit comments to the docket, send
information to the NIOSH Docket Office
by one of the following means:
Mail: NIOSH Docket Office, Robert A.
Taft Laboratories, C–34, 1090 Tusculum
Avenue, Cincinnati, Ohio 45226.
Email: nioshdocket@cdc.gov.
Telephone: (513) 533–8611.
In the event an individual cannot
attend, written comments may be
submitted. The comments should be
limited to two pages and submitted
through https://www.regulations.gov by
November 27, 2015. Efforts will be made
to provide the two-page written
comments received by the deadline
below to the committee members before
the meeting. Comments in excess of two
pages will be made publicly available at
https://www.regulations.gov. To view
background information and previous
submissions go to NIOSH docket
https://www.cdc.gov/niosh/docket/
archive/docket248.html , https://
www.cdc.gov/niosh/docket/archive/
docket248–A.html, and https://
www.cdc.gov/niosh/docket/archive/
docket248–B.html.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to https://www.regulations.gov within 60
days after the meeting. If a person
making a comment gives his or her
name, no attempt will be made to redact
that name. NIOSH will take reasonable
steps to ensure that individuals making
public comments are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public Web site. Such reasonable steps
include a statement read at the start of
the meeting stating that transcripts will
be posted and names of speakers will
not be redacted. If individuals in
making a statement reveal personal
VerDate Sep<11>2014
22:39 Oct 20, 2015
Jkt 238001
information (e.g., medical information)
about themselves, that information will
not usually be redacted. The CDC
Freedom of Information Act coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and, if deemed
appropriate, will redact such
information. Disclosures of information
concerning third party medical
information will be redacted.
Contact Person for More Information:
Paul J. Middendorf, Ph.D., Designated
Federal Officer, NIOSH, CDC, 2400
Century Parkway NE., Mail Stop E–20,
Atlanta, GA 30345, telephone 1 (888)
982–4748; email: wtc-stac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–26759 Filed 10–20–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting: Advisory Board on Radiation
and Worker Health (ABRWH or
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Times and Dates: 8:15 a.m.–5 p.m.,
Pacific Time, November 18, 2015. 8:15
a.m.–4:30 p.m., Pacific Time, November
19, 2015.
Public Comment Time and Date: 5
p.m.–6 p.m.*, Pacific Time, November
18, 2015.
* Please note that the public comment
period ends at the time indicated above
or following the last call for comments,
whichever is earlier. Members of the
public who wish to provide public
comments should plan to attend the
public comment session at the start time
listed.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
63791
Place: Waterfront Hotel, 10
Washington Street, Oakland, California
94607, Phone: 510–379–2652; Fax: 510–
832–6228. Audio Conference Call via
FTS Conferencing. The USA toll-free,
dial-in number is 1–866–659–0537 with
a pass code of 9933701. Live Meeting
CONNECTION: https://
www.livemeeting.com/cc/cdc/join?id
GS59T7&role=attend&pw=ABRWH;
Meeting ID: GS59T7; Entry Code:
ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters For Discussion: The agenda
for the Advisory Board meeting
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 80, Number 203 (Wednesday, October 21, 2015)]
[Notices]
[Pages 63790-63791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26759]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number CDC-2015-0090; NIOSH 248-C]
Meeting: World Trade Center Health Program Scientific/Technical
Advisory Committee (WTCHP STAC or Advisory Committee), National
Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting of the aforementioned
committee:
Time and Date: 9 a.m.-5 p.m., Eastern Standard Time, December 1,
2015
Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New
York, New York 10278. This meeting is also available by teleconference.
The USA toll-free, dial-in number is 1-888-455-9749, and when prompted
enter passcode--6542002. To view the web conference, enter the
following web address in your web browser: https://odniosh.adobeconnect.com/wtchpstac/.
Public Comment Time and Date: 11:20 a.m.-12 p.m., Eastern Standard
Time, December 1, 2015
Please note that the public comment period ends at the time
indicated above or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up by
providing their name by mail, email, or telephone, at the addresses
provided below by November 27, 2015. Each commenter will be provided up
to five minutes for comment. A limited number of time slots are
available and will be assigned on a first come-first served basis.
Written comments will also be accepted from those unable to attend the
public session.
Status: Open to the public, limited only by the number of telephone
lines. The conference line will accommodate up to 50 callers; therefore
it is suggested that those interested in calling in to listen to the
committee meeting share a line when possible.
Background: The Advisory Committee was established by Public Law
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010,
Title XXXIII of the Public Health Service Act), enacted on January 2,
2011 and codified at 42 U.S.C. 300mm-300mm-61.
Purpose: The purpose of the Advisory Committee is to review
scientific and medical evidence and to make recommendations to the
Administrator of the World Trade Center (WTC) Health Program regarding
additional WTC Health Program eligibility criteria and potential
additions to the list of covered WTC-related health conditions, as well
as providing consultation on research to the Administrator of the World
Trade Center Health Program. Title XXXIII of the Public Health Service
Act established within the Department of Health and Human Services
(HHS), the World Trade Center (WTC) Health Program, to be administered
by the Administrator of the World Trade Center Health Program. The WTC
Health Program provides: (1) Medical monitoring and treatment benefits
to eligible emergency responders and recovery and cleanup workers
(including those who are Federal employees) who responded to the
September 11, 2001, terrorist attacks, and (2) initial health
evaluation, monitoring, and treatment benefits to residents and other
building occupants and area workers in New York City, who were directly
impacted and adversely affected by such attacks (``survivors'').
Certain specific activities of the Administrator of the World Trade
Center Health Program are reserved to the Secretary, HHS, to delegate
at her discretion; other duties of the Administrator of the World Trade
Center Health Program not explicitly reserved to the Secretary, HHS,
are assigned to the Director, NIOSH. The administration of the Advisory
Committee established under Section 300mm-1(a) is left to the Director
of NIOSH in his role as Administrator of the World Trade Center Health
Program. CDC and NIOSH provide funding,
[[Page 63791]]
staffing, and administrative support services for the Advisory
Committee. The charter was reissued on May 12, 2015, and will expire on
May 12, 2017.
Matters for Discussion: The Advisory Committee will continue its
deliberations from the meeting on June 4, 2015, addressing the need for
research on developmental or health effects in children. The agenda
will include presentations on children's health research that has been
conducted related to exposures from the 9/11 terrorist attacks. Also, a
panel of children's researchers will discuss children's research issues
with the Advisory Committee.
The agenda is subject to change as priorities dictate.
Public Comment Sign-up and Submissions to the Docket: To sign up to
provide public comments or to submit comments to the docket, send
information to the NIOSH Docket Office by one of the following means:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories, C-34, 1090
Tusculum Avenue, Cincinnati, Ohio 45226.
Email: nioshdocket@cdc.gov.
Telephone: (513) 533-8611.
In the event an individual cannot attend, written comments may be
submitted. The comments should be limited to two pages and submitted
through https://www.regulations.gov by November 27, 2015. Efforts will
be made to provide the two-page written comments received by the
deadline below to the committee members before the meeting. Comments in
excess of two pages will be made publicly available at https://www.regulations.gov. To view background information and previous
submissions go to NIOSH docket https://www.cdc.gov/niosh/docket/archive/docket248.html , https://www.cdc.gov/niosh/docket/archive/docket248-A.html, and https://www.cdc.gov/niosh/docket/archive/docket248-B.html.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person
making a comment gives his or her name, no attempt will be made to
redact that name. NIOSH will take reasonable steps to ensure that
individuals making public comments are aware of the fact that their
comments (including their name, if provided) will appear in a
transcript of the meeting posted on a public Web site. Such reasonable
steps include a statement read at the start of the meeting stating that
transcripts will be posted and names of speakers will not be redacted.
If individuals in making a statement reveal personal information (e.g.,
medical information) about themselves, that information will not
usually be redacted. The CDC Freedom of Information Act coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and, if deemed appropriate, will redact such
information. Disclosures of information concerning third party medical
information will be redacted.
Contact Person for More Information: Paul J. Middendorf, Ph.D.,
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail
Stop E-20, Atlanta, GA 30345, telephone 1 (888) 982-4748; email: wtc-stac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-26759 Filed 10-20-15; 8:45 am]
BILLING CODE 4163-18-P
